Skip to content
Vaccine Security is Not Exclusive to Pfizer, Moderna, and Johnson & Johnson: Here’s Why
Summary
Small and mid-sized biotech firms in the vaccine pipeline are prime targets: attackers seek PHI, business system access, and R&D intellectual capital amid a 189% rise in healthcare phishing attacks.
- Published
- Collected